90 related articles for article (PubMed ID: 16300428)
1. Altered vulnerability to acute opiate withdrawal following stress: roles of N-methyl-D-aspartate and glucocorticoid receptors.
McNally GP; Lam S
Behav Neurosci; 2005 Oct; 119(5):1215-1221. PubMed ID: 16300428
[TBL] [Abstract][Full Text] [Related]
2. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
4. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
5. Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors.
del Rosario CN; Pacchioni AM; Cancela LM
Behav Brain Res; 2002 Aug; 134(1-2):229-38. PubMed ID: 12191809
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
7. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation.
Nair A; Bonneau RH
J Neuroimmunol; 2006 Feb; 171(1-2):72-85. PubMed ID: 16278020
[TBL] [Abstract][Full Text] [Related]
8. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
Harris AC; Atkinson DM; Aase DM; Gewirtz JC
Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512
[TBL] [Abstract][Full Text] [Related]
9. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal.
Higgins GA; Nguyen P; Sellers EM
Life Sci; 1992; 50(21):PL167-72. PubMed ID: 1533700
[TBL] [Abstract][Full Text] [Related]
10. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.
Navarro-Zaragoza J; Hidalgo JM; Laorden ML; Milanés MV
Br J Pharmacol; 2012 Aug; 166(7):2136-47. PubMed ID: 22364199
[TBL] [Abstract][Full Text] [Related]
12. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence.
Trujillo KA
Neuropsychopharmacology; 1995 Dec; 13(4):301-7. PubMed ID: 8747754
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
14. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
[TBL] [Abstract][Full Text] [Related]
16. NMDA Receptors in the Rat Paraventricular Thalamic Nucleus Reduce the Naloxone-induced Morphine Withdrawal.
Babaei F; Kourosh-Arami M; Farhadi M
Cent Nerv Syst Agents Med Chem; 2023; 23(2):119-125. PubMed ID: 37587828
[TBL] [Abstract][Full Text] [Related]
17. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
Medvedev IO; Dravolina OA; Bespalov AY
J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
